Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
ACE2 and SARS are reported together in 30 articles.
Gene
ACE2
- HGNC
- HGNC:13557
115articles
115mentions
10variants with confirmed gene link (top 10)
Most co-reported phenotypes (articles)
COVID-19 81SARS 30hypertension 8MERS 6diabetes mellitus 6obesity 6coronary artery disease 3lung cancer 2
Reported variants (articles · ClinVar status)
Phenotype
SARS
347articles
347mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
30 records shown · first 60Potential relationships between circulating gene expression of ACE2, TLR4, and IL-17 and disease severity and outcome of hospitalized patients with COVID-19.
PMID 41657067 | PMCID PMC12885613 | DOI 10.1631/jzus.B2400345 · Journal of Zhejiang University. Science. B · 2025 · 4 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “Potential relationships between circulating gene expression of ACE2, TLR4, and IL-17 and disease severity and outcome of hospitalized patients with COVID-19.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “The binding of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus spike protein to the cell membrane is mediated through its binding to angiotensin-converting enzyme 2 (ACE2) receptors, resulting in viral entry, replication, and induction of a signaling cascade inducing pro-inflammatory responses that are linked to a higher mortality rate and the progression of ARDS, leading to multi-organ failure in these patients.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | TLR4 | “Potential relationships between circulating gene expression of ACE2, TLR4, and IL-17 and disease severity and outcome of hospitalized patients with COVID-19.” | 0.98 | hgnc_dict_v1 |
| phenotype | COVID-19 | “Potential relationships between circulating gene expression of ACE2, TLR4, and IL-17 and disease severity and outcome of hospitalized patients with COVID-19.” | 0.98 | phenotype_alias_lexicon_v2 |
Molecular dynamic analyses of the interaction of SARS-CoV-1 or 2 variants with various angiotensin-converting enzyme-2 species.
PMID 38344933 | DOI 10.1080/07391102.2024.2314745 · Journal of biomolecular structure & dynamics · 2025 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “The transmembrane glycoprotein angiotensin-converting enzyme 2 (ACE2) is a key component of the renin-angiotensin system (RAS).” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “It was shown to be the receptor of severe acute respiratory syndrome coronavirus 2 in the COVID-19 outbreak (SARS-COV-2).” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “It was shown to be the receptor of severe acute respiratory syndrome coronavirus 2 in the COVID-19 outbreak (SARS-COV-2).” | 0.98 | phenotype_alias_lexicon_v2 |
Genetic risk factors for COVID-19 and influenza are largely distinct.
PMID 39103650 | PMCID PMC11319199 | DOI 10.1038/s41588-024-01844-1 · Nature genetics · 2024 · 5 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “These results mirror the observation that variants that downregulate ACE2, the SARS-CoV-2 receptor, protect against COVID-19 (ref.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “Coronavirus disease 2019 (COVID-19) and influenza are respiratory illnesses caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza viruses, respectively.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | B3GALT5 | “Furthermore, we discovered and replicated an association between influenza infection and noncoding variants in B3GALT5 and ST6GAL1, neither of which was associated with COVID-19.” | 0.98 | hgnc_dict_v1 |
| gene | ST6GAL1 | “Furthermore, we discovered and replicated an association between influenza infection and noncoding variants in B3GALT5 and ST6GAL1, neither of which was associated with COVID-19.” | 0.98 | hgnc_dict_v1 |
Non-synonymous Single Nucleotide Polymorphisms in Human ACE2 Gene May Affect the Infectivity of SARS-CoV-2 Omicron Subvariants.
PMID 38018194 | DOI 10.2174/0113816128275739231106055502 · Current pharmaceutical design · 2023 · 9 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “Non-synonymous Single Nucleotide Polymorphisms in Human ACE2 Gene May Affect the Infectivity of SARS-CoV-2 Omicron Subvariants.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the coronavirus disease 2019 (COVID-19), which first appeared in December 2019.” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the coronavirus disease 2019 (COVID-19), which first appeared in December 2019.” | 0.98 | phenotype_alias_lexicon_v2 |
| variant | A242V | “The missense mutations A242V, R708W, G405E, D292N, Y633C, F308L, and G405E in ACE2 receptor were found to interact with RBD of Omicron subvariants with stronger binding affinity.” | 0.82 | literature_variant_regex_v2 |
Mechanistic Insight and Possible Mechanism of Seizure in Covid-19: The Nuances and Focal Points.
PMID 35585806 | DOI 10.2174/1871527321666220517115227 · CNS & neurological disorders drug targets · 2023 · 4 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “SARS-CoV-2 shows neuroinvasive and neurotropic capabilities through a neuronal angiotensin-converting enzyme 2 (ACE2), which is also highly expressed in both neuronal and glial cells.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “COVID-19 is caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) and presents various neurological symptoms, including seizures.” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “Mechanistic Insight and Possible Mechanism of Seizure in Covid-19: The Nuances and Focal Points.” | 0.98 | phenotype_alias_lexicon_v2 |
| phenotype | epilepsy | “COVID-19 is caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) and presents various neurological symptoms, including seizures.” | 0.93 | phenotype_alias_lexicon_v2 |
The relevant information about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the five-question approach (when, where, what, why, and how) and its impact on the environment.
PMID 35175517 | PMCID PMC8852932 | DOI 10.1007/s11356-022-18868-x · Environmental science and pollution research international · 2023 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “The viral spike protein (S) significantly contributes to host cell entry, and mutations associated with it, particularly in the receptor-binding protein (RBD), either facilitate the escape of virus from neutralizing antibodies or enhance its transmission by increasing the affinity for cell entry receptor, angiotensin-converting enzyme 2 (ACE2).” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “The relevant information about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the five-question approach (when, where, what, why, and how) and its impact on the environment.” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “In addition, COVID-19 pointed on the possible solutions for the environmental pollution globe problem.” | 0.98 | phenotype_alias_lexicon_v2 |
In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing.
PMID 36808314 | PMCID PMC9939377 | DOI 10.1007/s00894-023-05457-z · Journal of molecular modeling · 2023 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “More than half of those mutations were found in the receptor-binding domain (RBD) that directly interacts with human angiotensin-converting enzyme 2 (ACE2).” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “BACKGROUND: In November 2021, variant B.1.1.529 of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified by the World Health Organization (WHO) and designated Omicron.” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “This study aimed to discover potent drugs against Omicron, which were previously repurposed for coronavirus disease 2019 (COVID-19).” | 0.98 | phenotype_alias_lexicon_v2 |
The potential role of scavenger receptor B type I (SR-BI) in SARS-CoV-2 infection.
PMID 37102664 | PMCID PMC10103078 | DOI 10.1002/iid3.786 · Immunity, inflammation and disease · 2023 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “SR-BI is colocalized with the angiotensin-converting enzyme 2 (ACE2) increasing the binding and affinity of SARS-CoV-2 to ACE2 with subsequent viral internalization.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “SR-BI is implicated as a receptor for entry of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2).” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “The potential role of scavenger receptor B type I (SR-BI) in SARS-CoV-2 infection.” | 0.93 | phenotype_alias_lexicon_v2 |
Evaluation of Potential Peptide-Based Inhibitors against SARS-CoV-2 and Variants of Concern.
PMID 37869628 | PMCID PMC10589072 | DOI 10.1155/2023/3892370 · BioMed research international · 2023 · 2 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “The angiotensin-converting enzyme (ACE2) receptor cell entry mechanism of this virus has not changed despite the vast mutation in emerging variants.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has greatly affected all aspect of life.” | 0.93 | phenotype_alias_lexicon_v2 |
Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes.
PMID 36531241 | PMCID PMC9748098 | DOI 10.3389/fgene.2022.1028081 · Frontiers in genetics · 2022 · 26 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “Background: Development and worldwide availability of safe and effective vaccines against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) to fight severe symptoms of coronavirus disease 2019 (COVID-19) and block the pandemic have been a great achievement and stimulated researchers on understanding the efficacy and duration of different vaccine types.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | TP53 | “Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes.” | 0.98 | hgnc_dict_v1 |
| gene | ABO | “Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes.” | 0.98 | hgnc_dict_v1 |
ACE2 polymorphisms impact COVID-19 severity in obese patients.
PMID 36513710 | PMCID PMC9748040 | DOI 10.1038/s41598-022-26072-7 · Scientific reports · 2022 · 8 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “ACE2 polymorphisms impact COVID-19 severity in obese patients.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “The expression of angiotensin converting enzyme 2 (ACE2), the main receptor for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is enhanced in obese individuals.” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “ACE2 polymorphisms impact COVID-19 severity in obese patients.” | 0.98 | phenotype_alias_lexicon_v2 |
| phenotype | obesity | “A strong association between obesity and COVID-19 complications and a lack of prognostic factors that explain the unpredictable severity among these patients still exist despite the various vaccination programs.” | 0.98 | phenotype_alias_lexicon_v2 |
Differential impact of the angiotensin-converting enzyme-2 (ACE2 rs4343 G>A) and miR-196a2 rs11614913 C>T gene alterations in COVID-19 disease severity and mortality.
PMID 35601073 | PMCID PMC9117950 | DOI 10.3892/etm.2022.11345 · Experimental and therapeutic medicine · 2022 · 7 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “Differential impact of the angiotensin-converting enzyme-2 (ACE2 rs4343 G>A) and miR-196a2 rs11614913 C>T gene alterations in COVID-19 disease severity and mortality.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “The recent coronavirus outbreak from Wuhan China in late 2019 caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) resulted in a global pandemic of coronavirus-19 disease (COVID-19).” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “Differential impact of the angiotensin-converting enzyme-2 (ACE2 rs4343 G>A) and miR-196a2 rs11614913 C>T gene alterations in COVID-19 disease severity and mortality.” | 0.98 | phenotype_alias_lexicon_v2 |
| phenotype | coronary artery disease | “A strong correlation between the ACE2 rs4343 G>A genotype distribution among COVID-19 patients was reported with respect to their comorbid conditions including sex (P<0.023), coronary artery disease (P<0.0001), oxygen saturation <60 mm Hg (P<0.0009) and antiviral therapy (0.003).” | 0.98 | phenotype_alias_lexicon_v2 |
Mutational analysis of the spike protein of SARS-COV-2 isolates revealed atomistic features responsible for higher binding and infectivity.
PMID 36733340 | PMCID PMC9888553 | DOI 10.3389/fcell.2022.940863 · Frontiers in cell and developmental biology · 2022 · 5 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “Protein-protein docking with Angiotensin-converting enzyme 2 (ACE2) and monoclonal antibody (4A8) revealed that mutation G446V in the receptor-binding domain; R102S and G181V in the N-terminal domain (NTD) significantly affected the binding and thus increased the infectivity.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “Introduction: The perpetual appearance of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2), and its new variants devastated the public health and social fabric around the world.” | 0.93 | phenotype_alias_lexicon_v2 |
| variant | G446V | “Protein-protein docking with Angiotensin-converting enzyme 2 (ACE2) and monoclonal antibody (4A8) revealed that mutation G446V in the receptor-binding domain; R102S and G181V in the N-terminal domain (NTD) significantly affected the binding and thus increased the infectivity.” | 0.82 | literature_variant_regex_v2 |
| variant | R102S | “Protein-protein docking with Angiotensin-converting enzyme 2 (ACE2) and monoclonal antibody (4A8) revealed that mutation G446V in the receptor-binding domain; R102S and G181V in the N-terminal domain (NTD) significantly affected the binding and thus increased the infectivity.” | 0.82 | literature_variant_regex_v2 |
Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions.
PMID 34924802 | PMCID PMC8667566 | DOI 10.1016/j.sjbs.2021.12.020 · Saudi journal of biological sciences · 2022 · 4 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “The effective indels were observed in the gene encoding the spike protein that is responsible for viral attachment to the angiotensin-converting enzyme 2 (ACE2) cell receptor and initiating infection.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “This study analyzes the evolutionary background of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or SARS-2) in accordance with its close relative SARS-CoV (SARS-1), which was emerged in 2002.” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “The emergence of coronavirus disease 2019 (COVID-19) pandemic in Wuhan city, China at the end of 2019 made it urgent to identify the origin of the causal pathogen and its molecular evolution, to appropriately design an effective vaccine.” | 0.98 | phenotype_alias_lexicon_v2 |
| phenotype | MERS | “A comparative genomic and proteomic study was conducted on SARS-2, SARS-1, and Middle East respiratory syndrome coronavirus (MERS), which was emerged in 2012.” | 0.98 | phenotype_alias_lexicon_v2 |
Antiviral Effects of Artemisinin and Its Derivatives against SARS-CoV-2 Main Protease: Computational Evidences and Interactions with ACE2 Allelic Variants.
PMID 35215242 | PMCID PMC8877620 | DOI 10.3390/ph15020129 · Pharmaceuticals (Basel, Switzerland) · 2022 · 4 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “Antiviral Effects of Artemisinin and Its Derivatives against SARS-CoV-2 Main Protease: Computational Evidences and Interactions with ACE2 Allelic Variants.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “To assess their potential use against COVID-19, the interactions of the main active principle of Artemisia with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro) was investigated through in silico probing.” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “Fighting against the emergent coronavirus disease (COVID-19) remains a big challenge at the front of the world communities.” | 0.98 | phenotype_alias_lexicon_v2 |
| variant | rs961360700 | “The best score was recorded with rs961360700.” | 0.90 | hgvs_regex_v1 |
Targeting the initiation and termination codons of SARS-CoV-2 spike protein as possible therapy against COVID-19: the role of novel harpagide 5-O-β-D-glucopyranoside from Clerodendrum volubile P Beauv. (Labiatae).
PMID 33140706 | PMCID PMC7651195 | DOI 10.1080/07391102.2020.1840439 · Journal of biomolecular structure & dynamics · 2022 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “It also displayed a very strong binding affinity with the translation initiation and termination sequence sites of spike (S) protein mRNA of SARS-COV-2, its gene product, and host ACE2 receptor.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “In silico analysis was used in determining its molecular interaction with severe acute respiratory syndrome coronavirus-2 (SARS-COV-2).” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “Targeting the initiation and termination codons of SARS-CoV-2 spike protein as possible therapy against COVID-19: the role of novel harpagide 5-O-β-D-glucopyranoside from Clerodendrum volubile P Beauv. (Labiatae).” | 0.98 | phenotype_alias_lexicon_v2 |
Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor.
PMID 34955621 | PMCID PMC8686452 | DOI 10.1016/j.jksus.2021.101773 · Journal of King Saud University. Science · 2022 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread around the world jeopardizing the global economy and health.” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread around the world jeopardizing the global economy and health.” | 0.98 | phenotype_alias_lexicon_v2 |
Lipopolysaccharide induces acute lung injury and alveolar haemorrhage in association with the cytokine storm, coagulopathy and AT1R/JAK/STAT augmentation in a rat model that mimics moderate and severe Covid-19 pathology.
PMID 35066912 | DOI 10.1111/1440-1681.13620 · Clinical and experimental pharmacology & physiology · 2022 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “Progress in the study of Covid-19 disease in rodents has been hampered by the lack of angiotensin-converting enzyme 2 (ACE2; virus entry route to the target cell) affinities for the virus spike proteins across species.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “A severe acute respiratory syndrome (SARS)-like effect was observed in the model group as demonstrated by the development of a "cytokine storm" (>2.7 fold increase in blood levels of IL-6, IL-17A, GM-CSF, and TNF-α), high blood ferritin, demonstrable coagulopathy, including elevated D-dimer (approximately 10-fold increase), PAI-1, PT, and APTT (p < 0.0001).” | 0.98 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “Lipopolysaccharide induces acute lung injury and alveolar haemorrhage in association with the cytokine storm, coagulopathy and AT1R/JAK/STAT augmentation in a rat model that mimics moderate and severe Covid-19 pathology.” | 0.98 | phenotype_alias_lexicon_v2 |
The role of angiotensin-converting enzyme 2 (ACE2) genetic variations in COVID-19 infection: a literature review.
PMID 37521836 | PMCID PMC9142348 | DOI 10.1186/s43042-022-00309-6 · The Egyptian journal of medical human genetics · 2022 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “The role of angiotensin-converting enzyme 2 (ACE2) genetic variations in COVID-19 infection: a literature review.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “BACKGROUND: The angiotensin-converting enzyme-2 (ACE2) is recognized to be the fundamental receptor of severe acute respiratory syndrome coronavirus-2 (SARS-CoV2), responsible for the worldwide Coronavirus Disease-2019 (COVID-19) epidemic.” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “The role of angiotensin-converting enzyme 2 (ACE2) genetic variations in COVID-19 infection: a literature review.” | 0.98 | phenotype_alias_lexicon_v2 |
'All In One' SARS-CoV-2 variant recognition platform: Machine learning-enabled point of care diagnostics.
PMID 35036904 | PMCID PMC8743487 | DOI 10.1016/j.biosx.2022.100105 · Biosensors & bioelectronics: X · 2022 · 2 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “Angiotensin Converting Enzyme 2 (ACE2), an enzymatic receptor, is chosen to be the biorecognition unit due to its high binding affinity towards spike proteins as a key-lock model.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “Point of care (PoC) devices are highly demanding to control current pandemic, originated from severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2).” | 0.93 | phenotype_alias_lexicon_v2 |
An in silico approach unveils the potential of antiviral compounds in preclinical and clinical trials as SARS-CoV-2 omicron inhibitors.
PMID 35475118 | PMCID PMC9026959 | DOI 10.1016/j.sjbs.2022.103297 · Saudi journal of biological sciences · 2022 · 2 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “In this study, molecular docking experiments were carried out using the recently reported experimental structure of omicron spike protein in complex with human angiotensin-converting enzyme 2 (ACE2) and various antivirals in preclinical and clinical trial studies.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “The increased transmissibility and highly infectious nature of the new variant of concern (VOC) that is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron and lack of effective therapy need the rapid discovery of therapeutic antivirals against it.” | 0.93 | phenotype_alias_lexicon_v2 |
Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells.
PMID 36014919 | PMCID PMC9415163 | DOI 10.3390/nu14163417 · Nutrients · 2022 · 2 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “Our results show that depletion of cholesterol in the rafts by methyl-beta-cyclodextrin (MβCD) treatment impaired the expression of the cell surface receptor angiotensin-converting enzyme 2 (ACE2), resulting in a significant increase in SARS-CoV-2 entry into cells.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “However, the involvement of membrane cholesterol-rich lipid rafts in the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into target cells is not well known.” | 0.93 | phenotype_alias_lexicon_v2 |
Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism.
PMID 33525415 | PMCID PMC7865913 | DOI 10.3390/molecules26030673 · Molecules (Basel, Switzerland) · 2021 · 8 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection inducing coronavirus disease 2019 (COVID-19) is still an ongoing challenge.” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection inducing coronavirus disease 2019 (COVID-19) is still an ongoing challenge.” | 0.98 | phenotype_alias_lexicon_v2 |
| phenotype | malaria | “Chloroquine (CQ) and its metabolite hydroxychloroquine (HCQ) are mainly used to prevent and treat malaria and rheumatic diseases.” | 0.98 | phenotype_alias_lexicon_v2 |
Covid-19 and development of heart failure: mystery and truth.
PMID 34480616 | PMCID PMC8417660 | DOI 10.1007/s00210-021-02147-6 · Naunyn-Schmiedeberg's archives of pharmacology · 2021 · 4 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “In reality, the expression of cardiac ACE2 is implicated as a target point for SARS-CoV-2-induced acute cardiac injury.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “Coronavirus disease 2019 (Covid-19) is a novel worldwide pandemic caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “Covid-19 and development of heart failure: mystery and truth.” | 0.98 | phenotype_alias_lexicon_v2 |
| phenotype | hypertension | “Hypoxic respiratory failure, as in pulmonary edema, severe acute lung injury (ALI), and acute respiratory distress syndrome (ARDS) may affect heart hemodynamic stability due to the development of pulmonary hypertension.” | 0.98 | phenotype_alias_lexicon_v2 |
Relevance between COVID-19 and host genetics of immune response.
PMID 34305429 | PMCID PMC8285220 | DOI 10.1016/j.sjbs.2021.07.037 · Saudi journal of biological sciences · 2021 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “SARS-CoV-2 infection is mediated by the binding of virus spike protein to Angiotensin Converting Enzyme 2 (ACE2).” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “The outbreak of coronavirus disease 2019 (COVID-19) was caused by the newly emerged corona virus (2019-nCoV alias SARS-CoV-2) that resembles the severe acute respiratory syndrome virus (SARS-CoV).” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “Relevance between COVID-19 and host genetics of immune response.” | 0.98 | phenotype_alias_lexicon_v2 |
Anti-Viral and Immunomodulatory Properties of Propolis: Chemical Diversity, Pharmacological Properties, Preclinical and Clinical Applications, and In Silico Potential against SARS-CoV-2.
PMID 34441553 | PMCID PMC8391193 | DOI 10.3390/foods10081776 · Foods (Basel, Switzerland) · 2021 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “Molecular docking studies have demonstrated high binding affinities of propolis derivatives to multiple SARS-CoV-2 proteins, including 3C-like protease (3CLpro), papain-like protease (PLpro), RNA-dependent RNA polymerase (RdRp), the receptor-binding domain (RBD) of the spike protein (S-protein), and helicase (NSP13), as well as to the viral target angiotensin-converting enzyme 2 (ACE2).” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “As an antiviral agent, propolis and various constituents have shown promising preclinical efficacy against adenoviruses, influenza viruses, respiratory tract viruses, herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), human immunodeficiency virus (HIV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | COVID-19 | “Measures of drug-likeness parameters, including metabolism, distribution, absorption, excretion, and toxicity (ADMET) characteristics, also support the potential of propolis as an effective agent to combat COVID-19.” | 0.98 | phenotype_alias_lexicon_v2 |
Anti-COVID-19 activity of some benzofused 1,2,3-triazolesulfonamide hybrids using in silico and in vitro analyses.
PMID 34538993 | PMCID PMC8434689 | DOI 10.1016/j.chemolab.2021.104421 · Chemometrics and intelligent laboratory systems : an international journal sponsored by the Chemometrics Society · 2021 · 2 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “The derivatives 4b and 4c were examined in vitro for their potential anti-SARS-CoV-2 and it was revealed that 4c was the most promising compound with IC50 reached 758.8108 mM and complete (100%) inhibition of the binding of SARS-CoV-2 virus to human ACE2 can be accomplished by using 0.01 mg.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pandemic fatal infection with no known treatment.” | 0.93 | phenotype_alias_lexicon_v2 |
Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD.
PMID 32537478 | PMCID PMC7242205 | DOI 10.1016/j.omtm.2020.05.013 · Molecular therapy. Methods & clinical development · 2020 · 5 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “It has been reported that angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) are the main cell entry proteins for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and play a critical role in causing coronavirus disease 2019 (COVID-19).” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | TMPRSS2 | “Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD.” | 0.98 | hgnc_dict_v1 |
| phenotype | COVID-19 | “It has been reported that angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) are the main cell entry proteins for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and play a critical role in causing coronavirus disease 2019 (COVID-19).” | 0.98 | phenotype_alias_lexicon_v2 |
SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype.
PMID 32628976 | PMCID PMC7833925 | DOI 10.1016/j.gene.2020.144944 · Gene · 2020 · 5 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “For this reason, we investigated the involvement of genetic factors associated with SARS-CoV-2 infection with a focus on angiotensin-converting enzyme (ACE)-related genes, because ACE2 is a receptor for SARS-CoV-2.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19).” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | ACE | “For this reason, we investigated the involvement of genetic factors associated with SARS-CoV-2 infection with a focus on angiotensin-converting enzyme (ACE)-related genes, because ACE2 is a receptor for SARS-CoV-2.” | 0.98 | hgnc_dict_v1 |
| phenotype | COVID-19 | “SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype.” | 0.98 | phenotype_alias_lexicon_v2 |
Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies.
PMID 33137894 | PMCID PMC7663346 | DOI 10.3390/molecules25215007 · Molecules (Basel, Switzerland) · 2020 · 4 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACE2 | “SARS-CoV2 infection depends on the host cell Angiotensin-Converting Enzyme-2 (ACE2) and Transmembrane Serine Protease-2 (TMPRSS2), where the virus uses ACE2 for entry and TMPRSS2 for S protein priming.” | 0.98 | hgnc_dict_v1 |
| phenotype | SARS | “The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), which caused novel corona virus disease-2019 (COVID-19) pandemic, necessitated a global demand for studies related to genes and enzymes of SARS-CoV2.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | TMPRSS2 | “SARS-CoV2 infection depends on the host cell Angiotensin-Converting Enzyme-2 (ACE2) and Transmembrane Serine Protease-2 (TMPRSS2), where the virus uses ACE2 for entry and TMPRSS2 for S protein priming.” | 0.98 | hgnc_dict_v1 |
| phenotype | COVID-19 | “The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), which caused novel corona virus disease-2019 (COVID-19) pandemic, necessitated a global demand for studies related to genes and enzymes of SARS-CoV2.” | 0.98 | phenotype_alias_lexicon_v2 |